| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhang,Xiao-Li | Chairman | 3.79% | |
| Chen,Wei-Ren | Director | 28.94% | SYNGEN BIOTECH CO.,LTD. |
| Fan,Zi-Ting | Director | 28.94% | SYNGEN BIOTECH CO.,LTD. |
| Ji,Yi-Ren | Director | 2.05% | SONG YIEN ENZYME CORPORATION |
| Yao,Yi-Jun | Director | 5.17% | STANDARD FOODS CORPORATION |
| Jin,Jin-De | Director | 1.15% | |
| Chen,Zong-Min | Independent Director | 0.00% | |
| Qiu,Fang-Cai | Independent Director | 0.00% | |
| Huang,Yu-Qi | Independent Director | 0.00% | |
| Hong,Xiao-Ping | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 166,427 | 521,163 | 793,770 |
| Operating cost | 124,231 | 424,418 | 507,419 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 42,196 | 96,745 | 286,351 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 42,196 | 96,745 | 286,351 |
| Operating expenses | 35,146 | 131,153 | 132,786 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 7,050 | -34,408 | 153,565 |
| Non-operating income and expenses | 833 | 6,943 | -132 |
| Net profit (loss) before tax | 7,883 | -27,465 | 153,433 |
| Income tax expense (benefits) | 1,412 | -4,937 | 28,812 |
| Net profit (loss) of ongoing business for the current period | 6,471 | -22,528 | 124,621 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 6,471 | -22,528 | 124,621 |
| Other comprehensive profit (loss), net | 375 | 795 | -365 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 6,846 | -21,733 | 124,256 |
| Net profit (loss) attributable to owners of parent company | 6,471 | -22,528 | 124,621 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 6,846 | -21,733 | 124,256 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 0 | 3 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 28,571 | 8,090 | 190,313 |
| Net cash inflows (outflows) from investing activities | -5,043 | -22,828 | -70,617 |
| Net cash inflow (outflow) from financing activities | 110,898 | 16,382 | -99,874 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 373 | 653 | -359 |
| Increase (decrease) in cash and cash equivalents in the current period | 134,799 | 2,297 | 19,463 |
| Beginning balance of cash and cash equivalents | 122,450 | 120,153 | 100,690 |
| Ending balance of cash and cash equivalents | 257,249 | 122,450 | 120,153 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 531,307 | 411,971 | 397,132 |
| Non-current asset | 717,924 | 734,524 | 778,243 |
| Total asset | 1,249,231 | 1,146,495 | 1,175,375 |
| Current liability | 126,701 | 134,259 | 189,859 |
| Non-current liability | 327,500 | 224,052 | 92,679 |
| Total liability | 454,201 | 358,311 | 282,538 |
| share capital | 414,598 | 414,598 | 414,598 |
| Equity - secruity token | - | - | - |
| capital reserve | 294,336 | 294,336 | 294,336 |
| retained earning | 87,851 | 81,380 | 186,693 |
| Other equity | -1,755 | -2,130 | -2,790 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 795,030 | 788,184 | 892,837 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 795,030 | 788,184 | 892,837 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 19 | 19 | 21 |
